Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
DETAILED ACTION
Status of objections and rejections
1. Claims 1, 2, 4-7, 9, 11 and 13 are pending. Claims 3, 8, 10, 12 and 14-20 are cancelled. Accordingly, claims 1, 2, 4-7, 9, 11 and 13 are examined on merits in the instant Office action.
2. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action.
3. Rejection of Claims 1, 2, 4-7, 9, 11 and 13 under 35 U.S.C. 112(a), first paragraph, as failing to comply with the written description requirement is withdrawn in light of amendments to the claims filed in the papers of July 16, 2026 and upon further consideration.
4. Rejection of claim(s) 1, 2, 4-7, 9, 11 and 13 under 35 U.S.C. 103 as being unpatentable over Li et al. (CN 106834305 A, pages 1-24, English translation attached with the foreign document, Published March 16, 2017), and Ren et al. (The Plant Journal, 98:315-328, Published December 27, 2018 supplementary documents attached), and further in view of Zhang et al. (CN 102586278 A, pages 1-24, English translation attached with the foreign document, Published March 16, 2017), Wahler et al. (GenBank Sequence Accession NO. KF036176.1, pages 1-2, Published July 2013), Xu et al. (Rice, 7:5, pages 1-4, published 2014, supplementary documents attached) and Zhao et al. (J. Plant Biol., 59:496-505, Published 2016, supplementary documents attached) is withdrawn in light of amendments to the claims filed in the papers of July 16, 2026 and upon further consideration.
Claim Rejections - 35 USC § 112 (Scope of Enablement)
5. Claims 1, 2, 4-7, 9, 11 and 13 remain rejected under the first paragraph of 35 U.S.C. § 112(a). While the specification is enabling for a method of breeding a recessive genetic male sterile line of a rice sporophyte, comprising transforming a rice male sterile mutant plant, Zhongjiu B-osabcg15 (carrying a mutation in the endogenous OsABCG15 gene), with a plant transformation vector designated pAR-Xi-Y-Bi-C, which comprises a multigene construct having the nucleotide sequences set forth in SEQ ID NOs: 6, 11, 17, 18 and 20, wherein expression of said multigene construct, followed by breeding, purity identification, and improvement of the genetic male sterile Zhongjiu B-osabcg15 sporophyte, results in production of a recessive genetic male sterile line of a rice sporophyte, it does not reasonably provide enablement for: (i) any sporophyte; (ii) any interference sequence directed to the gametophyte male sterility–related OsPTD1 gene; and (iii) producing a recessive genetic male sterile rice sporophyte line using any method that does not involve transformation with a plant transformation vector designated pAR-Xi-Y-Bi-C comprising said multigene construct. The specification does not enable a person skilled in the art to which it pertains, or with which it is most nearly connected, to make and/or use the invention commensurate in scope with these claims, for the reasons of record stated in the Office action mailed April 16, 2026.
Applicant primarily argues that the claims have been amended to overcome this rejection.
Applicant’s arguments have been carefully considered but are deemed persuasive only in part. While most of the issues have been addressed through Applicant’s claim amendments, three
issues identified in the body of the rejection remain pending, for the reasons of record.
To overcome this rejection, Applicant is advised to do the following:
(i) clearly recite in the claims that the plant is a rice sporophyte, so that the claims do not read on any sporophyte while relying on rice endogenous gene(s) to practice the method;
(ii) clearly recite that the method involves plant transformation using the multigene construct; and
(iii) move the limitation of claim 4 (i.e., SEQ ID NO: 20) into parent claim 1.
In the absence of guidance or suggested claim amendments, it is maintained that undue experimentation would be required to increase or down-regulate expression of endogenous genes by means not involving plant transformation with an appropriate DNA construct directed to increasing expression of said genetic elements, in any plant species, including rice, as encompassed by the breadth of the claims.
Accordingly, given the breadth of the claims, the unpredictability of the art, and the lack of guidance in the specification, as discussed above, it is maintained that undue experimentation would be required for one skilled in the art to make and use the claimed invention commensurate in scope with the claims.
Conclusion
6. Claims 1, 2, 4-7, 9, 11 and 13 remain rejected.
THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a).
A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action.
Contact Information
Any inquiry concerning this communication or earlier communications from the examiner should be directed to Vinod Kumar whose telephone number is (571) 272-4445. The examiner can normally be reached on 8.30 a.m. to 5.00 p.m.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Amjad A. Abraham can be reached on (571) 270-7058 The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA).
/VINOD KUMAR/Primary Examiner, Art Unit 1663